These findings suggest potential disruptions in SWI/SNF complex integrity, aligning with prior reports indicating that a subset of SMARCB1‐driven neoplasms may retain INI1 expression while selectively losing BRG1 [16, 17, 18, 19, 20]. The gene discussed is SMARCA4; the disease is neoplasm.